Abstract: Thermoplastic molding compositions containing grafted polymers produced with different initiator systems are disclosed. The compositions are distinguished by a combination of good toughness and reduced opacity. As a result, appreciably smaller quantities of pigment are needed to color the molding composition.
Abstract: Nucleic acid molecules are described encoding a starch granule-bound protein from maize as well as methods and recombinant DNA molecules for the production of transgenic plant cells and plants synthesizing a modified starch. Moreover, the plant cells and plants resulting from those methods as well as the starch obtainable therefrom are described.
Abstract: The present invention relates to novel microbicidal compositions based on biphenylbenzamide derivatives of the formula (I) in which R1, R2, R3 and m are as defined in the disclosure, to novel biphenylbenzamides, to a plurality of processes for preparing these substances and their use for controlling pests, and to novel intermediates and processes for their preparation.
Abstract: The invention relates to novel heterocyclic enaminones of the general formula (I) in which Ar, Z, K, X, Y1, Y2, Y3, Y4, Y5, Y6 and V are as defined in the description, to their use as herbicides, acaricides and insecticides, and to processes for their preparation.
Type:
Grant
Filed:
November 21, 2000
Date of Patent:
March 6, 2007
Assignee:
Bayer Aktiengesellschaft
Inventors:
Reiner Fischer, Ralf Wischnat, Jutta Böhmer, Axel Trautwein, Jürgen Wiedemann, Udo Schneider, Hermann Hagemann, Mark Wilhelm Drewes, Peter Dahmen, Rolf Pontzen, Dieter Feucht, Christoph Erdelen, Peter Lösel
Abstract: An analyzer for performing automated assay testing. The analyzer includes a storage and conveyor system for conveying cuvettes to an incubation or processing conveyor, a storage and selection system for test sample containers, a storage and selection system for reagent containers, sample and reagent aspirating and dispensing probes, a separation system for separating bound from unbound tracer or labeled reagent, a detection system and date collection/processing system. All of the subunits of the machine are controlled by a central processing unit to coordinate the activity of all of the subunits of the analyzer. The analyzer is specifically suited for performing heterogeneous binding assay protocols, particularly immunoassays.
Type:
Grant
Filed:
May 29, 2002
Date of Patent:
February 27, 2007
Assignee:
Bayer Corporation
Inventors:
Glen Carey, Scott C. Lewis, Mary Beth Whitesel, Frank C. Klingshirn
Abstract: The present invention relates to novel [1,2]-oxazine-3,5-dione derivatives of the formula (I) in which W, X, Y, Z, G, D, A and B are as defined in the disclosure, to a plurality of processes for their preparation, and to their use as microbicides, pesticides and herbicides.
Type:
Grant
Filed:
November 27, 2002
Date of Patent:
February 27, 2007
Assignee:
Bayer CropScience AG
Inventors:
Reiner Fischer, Thomas Schenke, Angelika Lubos-Erdelen, legal representative, Christoph Erdelen, deceased
Abstract: The invention claimed herein is a kit for detecting biologically active substances on a support, comprising the luminescent marine bacteria Vibria Fischeri in a form stabilized for transport and storage, one or more cultivation media or the individual components of cultivation media for the microorganism wherein the cultivation media contains 100 mg/l to 500 mg/l of aspartic acid, and optionally additives for extending the period of luminescence selected from N-acylhomoserine lactones, dipeptides, oligopeptides, or their biochemical precursors, and boron compounds.
Type:
Grant
Filed:
April 25, 2003
Date of Patent:
February 27, 2007
Assignee:
Bayer Aktiengesellschaft
Inventors:
Wolfgang Kreiss, Guenther Eberz, Hans-Georg Rast, Claus Weisemann
Abstract: A system and method of correcting reflectance comprises determining a reflectance constant for a test product at a first wavelength for which reflectance does not substantially change with the presence of a test substance, with the test product loaded with the test substance, determining a reflectance at a second wavelength for which signal-to-noise ratio is maximized and determining a measured reflectance at the first wavelength, and determining a corrected reflectance as the product of the reflectance with a ratio of the reflectance constant to the measured reflectance.
Abstract: The invention relates to the photoprotein berovin, to its nucleotide and amino acid sequences and to the activity and use of the photoprotein berovin.
Abstract: The invention concerns a new method for automatically and dynamically generating hierarchical topological trees of 2D- or 3D-structural formulas for structurally characterized chemical compounds, especially drug-like molecules, wherein the molecular graph of each 2D- or 3D-structure for a chemical compound is analyzed in terms of topological key features, the Largest Topological Substructure (LTS) and the proper Topological Cluster Centre (TCC) are created for each molecular graph, the ranking of the classes of topological key features and/or the ranking within each class of topological key features present in the TCC is used to generate a connected hierarchical Topological Sequence Path (TSP) of sentinel molecules from each molecular graph, and different molecular graphs and their Topological Sequence Paths (TSPs) share common vertices for common topological key features thus growing a Topological Structure Tree (TST), each chemical compound from the input stream is attached as a leaf node to the appropriate
Abstract: The invention relates to a method for directly detecting the modification of a molecule containing a fluorescent dye by measuring the fluorescence lifetime.
Abstract: A structural element of closed-cell polyurethane rigid foam, with good thermal insulation and improved sound absorption is achieved by means of surface depressions satisfying specified criteria.
Abstract: The present invention relates to compositions for controlling plant pests containing the compound of the formula (I) in a mixture with specified fungicidally active compounds.
Type:
Grant
Filed:
August 23, 2004
Date of Patent:
February 20, 2007
Assignee:
Bayer Aktiengesellschaft
Inventors:
Christoph Erdelen, Wolfram Andersch, Klaus Stenzel, Astrid Mauler-Machnik, Wolfgang Krämer
Abstract: The invention relates to novel ?1-pyrrolines of the formula (I) in which R1, R2, R3, m, and Q have the meanings given in the disclosure, to a plurality of processes for preparing these substances, and to their use for controlling pests.
Type:
Grant
Filed:
November 22, 2001
Date of Patent:
February 20, 2007
Assignee:
Bayer Cropscience AG
Inventors:
Andrew Plant, Thomas Seitz, Johannes Rudolf Jansen, Christoph Erdelen, Andreas Turberg, Olaf Hansen
Abstract: The present invention relates to low viscosity polymer polyols and to a process for the preparation of these low viscosity polymer polyols. These polymer polyols comprise the free-radical polymerization product of (A) a base polyol, (B) a pre-formed stabilizer, and (C) at least one ethylenically unsaturated monomer, in the presence of (D) at least one free-radical polymerization initiator, and (E) at least one polymer control agent. The total amount of polymer control agent present in the polymer polyols of the present invention ranges from greater than about 5.0% up to about 20% by weight, based on 100% by weight of the polymer polyol.
Type:
Grant
Filed:
August 2, 2004
Date of Patent:
February 20, 2007
Assignee:
Bayer Materialscience LLC
Inventors:
Rick L. Adkins, Scott A. Guelcher, James R. Charron, John E. Hayes
Abstract: Reagents that regulate human serine/threonine kinase and reagents which bind to human serine/threonine kinase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to, cancer, diabetes, neurological disorders, cardiovascular disorders, musculo-skeletal disorders, inflammatory disorders, genitourological disorders, and respiratory disorders (e.g., asthma and COPD).
Abstract: This invention relates to novel furancarboxamides of the formula (I) in which R, R1 and m are as defined in the disclosure, to a plurality of processes for preparing these substances and to their use for controlling unwanted micro-organisms.
Abstract: The invention provides a human AdipoR1 which is associated with the cardiovascular diseases, dermatological diseases, gastroenterological diseases, cancer, hematological diseases, inflammation, respiratory diseases, neurological diseases and urological diseases. The invention also provides assays for the identification of compounds useful in the treatment or prevention of cardiovascular diseases, dermatological diseases, gastroenterological diseases, cancer, hematological diseases, inflammation, respiratory diseases, neurological diseases and urological diseases. The invention also features compounds which bind to and/or activate or inhibit the activity of AdipoR1 as well as pharmaceutical compositions comprising such compounds.
Type:
Application
Filed:
September 16, 2004
Publication date:
February 15, 2007
Applicant:
BAYER HEALTHCARE AG
Inventors:
Stefan Golz, Ulf Bruggermeier, Andreas Geerts
Abstract: The present invention relates to a novel active compound combination which consists of the known 3-{1-[2-(4-<2-chlorophenoxy>-5-fluoropyrimid-6-yloxy)phenyl]-1-(methoximino)methyl}-5,6-dihydro-1,4,2-dioxazine (fluoxastrobin) and of other known active compounds and is highly suitable for controlling phytopathogenic fungi.
Type:
Application
Filed:
July 19, 2004
Publication date:
February 15, 2007
Applicant:
Bayer Cropscience Aktiengesellschaft
Inventors:
Peter Dahmen, Asrtid Mauler-Machnik, Anne Suty-Heinze, Friedrich Kerz-Mohlendick